| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Profit before tax | 0.1 | -12.8 |
| Net income | 0.1 | -12.8 |
| EPS (diluted, $ a share) | $0.01 | $-2.57 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
10-Q filed with the SEC, NASDAQ: SKYE. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Skye Bioscience, Inc.: key numbers
- Share price
- $1.07Close, Nov 16
- Market cap
- $4.71M
- Shares outstanding
- 4.42MLatest SEC cover page
- Sector
- Life Sciences
- Industry
- Pharmaceutical PreparationsSIC 2834
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Skye Bioscience, Inc.
All →Skye Bioscience Court & Legal Update
Skye Bioscience received a unanimous jury verdict in its favor following a retrial in the U.S. District Court for the Central District of California. The lawsuit, filed by a former employee, alleged whistleblower protection violations and retaliation related to events occurring between 2018 and 2019. The verdict clears the company of all claims, though the plaintiff retains the right to file post-trial motions or appeals.
- Counterparty
- Wendy Cunning
Skye Bioscience Director Andrew J. Schwab Sells $230K of Stock
Andrew J. Schwab, Director, sold 142,463 shares of Skye Bioscience, Inc. at $1.61 to $1.65 a share (average $1.62) in 2 transactions, worth $230K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $230K
- Shares
- 142,463
- Average price
- $1.62
- Role
- Director
- Holding change
- -100.0%
- Trade date
- Sep 22, 2026 to Sep 23, 2026
Skye Bioscience 10% Owner 5AM Partners VII LLC Sells $230K of Stock
5AM Partners VII LLC, 10% Owner, sold 142,463 shares of Skye Bioscience, Inc. at $1.61 to $1.65 a share (average $1.62) in 2 transactions, worth $230K in total between Sep 22, 2026 and Sep 23, 2026. Shares held after the trade: 0 (-100.0%).
- Value
- $230K
- Shares
- 142,463
- Average price
- $1.62
- Role
- 10% Owner
- Holding change
- -100.0%
- Trade date
- Sep 22, 2026 to Sep 23, 2026
Skye Bioscience Director Andrew J. Schwab Sells $62.3K of Stock
Andrew J. Schwab, Director, sold 32,607 shares of Skye Bioscience, Inc. at $1.91 a share, worth $62.3K in total on Sep 16, 2026. Shares held after the trade: 142,463 (-18.6%).
- Value
- $62.3K
- Shares
- 32,607
- Price
- $1.91
- Role
- Director
- Holding change
- -18.6%
- Trade date
- Sep 16, 2026
Skye Bioscience 10% Owner 5AM Partners VII LLC Sells $62.3K of Stock
5AM Partners VII LLC, 10% Owner, sold 32,607 shares of Skye Bioscience, Inc. at $1.91 a share, worth $62.3K in total on Sep 16, 2026. Shares held after the trade: 142,463 (-18.6%).
- Value
- $62.3K
- Shares
- 32,607
- Price
- $1.91
- Role
- 10% Owner
- Holding change
- -18.6%
- Trade date
- Sep 16, 2026